Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
actinomycetales infections
MeSH D000193 - actinomycetales infections
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D016908:
Gram-positive bacterial infections
47 Companies
13 Drugs
$
Success rate
D000193:
Â
Actinomycetales infections
42 Companies
4 Drugs
$
Success rate
D000196:
Actinomycosis
48 Companies
14 Drugs
$
Success rate
D003354:
Corynebacterium infections
0 Companies
0 Drugs
Success rate
D009164:
Mycobacterium infections
51 Companies
15 Drugs
$
Success rate
D009617:
Nocardia infections
44 Companies
6 Drugs
$
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
No data
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Clindamycin
Padagis
Benzoyl peroxide
,
Clindamycin
Taro Pharmaceutical
Benzoyl peroxide
,
Clindamycin
Glenmark Pharmaceuticals
Benzoyl peroxide
,
Clindamycin
Mylan
Benzoyl peroxide
Bausch Health Companies
Adapalene
,
Benzoyl peroxide
,
Clindamycin
,
Tretinoin
Pfizer
Clindamycin
Zydus Therapeutics
Benzoyl peroxide
,
Clindamycin
Sun Pharmaceutical Industries
Clindamycin
1
2
3
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use